Michael Good
Griffith University, QLD, Australia
- This delegate is presenting an abstract at this event.

Professor Michael Good AO heads the Laboratory of Vaccines for the Developing World at Griffith University’s Institute for Glycomics. His research interests are in immunity and vaccine development for malaria and Strep A. He and his team have developed candidate vaccines for both and are in Phase I clinical trials.
Presentations this author is a contributor to:
Low-dose interleukin-2 therapy: A transformative approach for the management of autoimmune complications associated with Streptococcus pyogenes infections (117139)
11:32 AM
Ailin Lepletier
Plenary 2 - New Insights and New Tools
Parenteral vaccination with a super immunogen targeting M-protein provides unprecedented protection against group A streptococcus (StrepA) respiratory infections (#187)
5:30 PM
Victoria Ozberk
Poster Session 1
Possibility of developing a biomarker based rapid screening test for ARF/RHD (#268)
5:30 PM
Brenda Vo
Poster Session 2